Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab Combined With Chemotherapy as Postoperative Adjuvant Therapy for Non-Small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy: A Two-Cohort, Multicenter Phase II Trial

NCT07039656 is registered in ClinicalTrials.gov with Wen-zhao ZHONG as lead sponsor.

NCT NCT07039656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab Combined With Chemotherapy as Postoperative Adjuvant Therapy for Non-Small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy: A Two-Cohort, Multicenter Phase II Trial
Lead sponsor
Wen-zhao ZHONG
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2030
Enrollment
211 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ib-iiib nsclc, stage iib-iii nsclc